DREAMM-9: Phase III study belantamab mafodotin plus VRd vs VRd alone in transplant-ineligible NDMM International Myeloma Foundation 1:33 4 years ago 233 Далее Скачать
DREAMM-9: belantamab mafodotin plus VRd vs VRd in TI NDMM VJHemOnc – Video Journal of Hematology & HemOnc 2:41 4 years ago 132 Далее Скачать
DREAMM-9: Phase I Study of Belantamab Mafodotin+Standard of Care in Pts w/Transplant-Ineligible NDMM International Myeloma Foundation 3:59 2 years ago 383 Далее Скачать
DREAMM-9 Blenrep + VRd vs VRd in Newly Diagnosed Transplant Ineligible Myeloma | Saad Usmani ASH21 HealthTree Foundation for Multiple Myeloma 2:24 2 years ago 164 Далее Скачать
DREAMM-9: Belantamab mafodotin + standard care in newly diagnosed multiple myeloma International Myeloma Foundation 6:39 1 year ago 225 Далее Скачать
DREAMM-3: safety of belantamab mafodotin versus pom/dex in patients with R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:02 1 year ago 145 Далее Скачать
IMROZ: Isa-VRd vs VRd for transplant-ineligible newly diagnosed multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:57 2 months ago 75 Далее Скачать
Isa-VRd vs VRd for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (IMROZ) International Myeloma Foundation 12:37 3 months ago 344 Далее Скачать
DREAMM-9: The potential role of belantamab mafodotin in the frontline treatment of multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:52 1 year ago 51 Далее Скачать
Daratumumab plus VMP for NDMM: ALCYONE follow-up VJHemOnc – Video Journal of Hematology & HemOnc 2:20 4 years ago 81 Далее Скачать
DREAMM-3: belantamab mafodotin vs pom/dex for R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:04 4 years ago 180 Далее Скачать
Dr Facon on the Implications of Isatuximab Plus VRd in Transplant-Ineligible Newly Diagnosed Myeloma OncLive 0:53 1 month ago 21 Далее Скачать
Overall Survival Results in Transplant-Ineligible Newly Diagnosed MM pts: Phase 3 MAIA Study International Myeloma Foundation 15:30 3 years ago 856 Далее Скачать
The safety and efficacy of Isa-VRd in patients with transplant-ineligible NDMM VJHemOnc – Video Journal of Hematology & HemOnc 2:03 10 months ago 53 Далее Скачать
DREAMM-5 Study of BLENREP (belantamab mafodotin) Combined with Nirogacestat in RRMM patients International Myeloma Foundation 2:14 2 years ago 316 Далее Скачать
Efficacy and safety of belantamab mafodotin vs pomalidomide plus dexamethasone in RRMM ecancer 3:09 1 year ago 16 Далее Скачать
GRIFFIN updates: D-RVd vs RVd in transplant-eligible patients with newly diagnosed multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:13 2 years ago 154 Далее Скачать
Isatuximab + Len/Dex/Bortezomib vs IsaRd in Newly Diagnosed Transplant Ineligible Multiple Myeloma International Myeloma Foundation 14:31 3 months ago 152 Далее Скачать
Belantamab mafodotin and its place in myeloma treatment VJHemOnc – Video Journal of Hematology & HemOnc 3:25 2 years ago 80 Далее Скачать
